Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Thrombolysis for acute ischaemic stroke has been investigated in several clinical trials, with variable results. We have assessed the safety and efficacy of intravenous thrombolysis with alteplase (0.9 mg/kg bodyweight) within 6 h of stroke onset.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Lancet

Title: Lancet (London, England)

Publisher: Elsevier BV

ISSN: 0140-6736

ISSN (Print): 0140-6736

Publication date (Electronic): Oct 17 1998

Volume: 352

Issue: 9136

Affiliations

[1 ] Department of Neurology, University of Heidelberg, Germany. wernervhacke@ukl.uni.heidelberg.de

Article

Publisher Item ID: S0140673698080209

DOI: 10.1016/s0140-6736(98)08020-9

PubMed ID: 9788453

SO-VID: 66436ad2-3e3c-437d-8179-3e04fbb470ab

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.